Published January 1, 2019
| Version v1
Journal article
Open
Antiangiogenic effect of bevacizumab in monoclonal antibodies in experimental inflammatory pain model
Creators
- 1. Kahramanmaras Sutcu Imam Univ, Tip Fak, Biyofiz Anabilim Dali, Kahramanmaras, Turkey
- 2. Tibbi Biyokimya Anabilim Dali, Kahramanmaras, Turkey
Description
Purpose: This study aimed to investigate the possible antinociceptive, anti-inflammatory and anti-edema effects of systemic (intaperitoneal) and local (intraplantar) bevacizumab in the experimental inflammation model (introduced with Carrageenan).
Files
bib-13d3320c-1ff5-4db4-b98b-9b30ab1ab038.txt
Files
(222 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:ddb3ff6a75ef789a0cb8e92b9e8c5d52
|
222 Bytes | Preview Download |